0Suppliers
1Customers
3Debt Items
6Related Chains
Standard BioTools Inc. Suppliers
No suppliers on recordStandard BioTools Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.
Standard BioTools Inc. Customers
| Ticker | Name | Confidence | Evidence |
| ILLUMINA |
ILLUMINA |
92%
|
On January 30, 2026, the Company completed the sale of the Disposed Entities to Illumina pursuant to the Purchase Agreement. |
Standard BioTools Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
| LAB-DEBT |
Debt stack $29.5M |
90%
|
Market cache reports total debt of $29.5M. |
| LAB-DEBT-10602 |
Warrants outstanding: -232000 |
90%
|
xbrl warrant detail from xbrl 2025-12-31. |
| LAB-DEBT-10603 |
Xbrl Convertible |
90%
|
xbrl convertible detail from xbrl 2024-12-31. |
Standard BioTools Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Standard BioTools Inc..
Standard BioTools Inc. Ownership
| Holder | Name | Confidence | Evidence |
| LAB-OWNER-CASDIN-CAPITAL-LLC |
Casdin Capital, LLC |
90%
|
13F overlay lists Casdin Capital, LLC as top holder; 155 tracked holders. |
Standard BioTools Inc. Extended Supply Chain Network
| Ticker | Name | Chain Index | Hops | Relationship Types |
| BDX |
Becton, Dickinson and Company |
100.00 |
2 |
|
| AMGN |
Amgen Inc. |
50.00 |
2 |
|
| WAT |
Waters Corporation |
50.00 |
2 |
|
| AMGEN |
AMGEN |
50.00 |
2 |
|
| NAUT |
Nautilus Biotechnology, Inc. |
42.84 |
1 |
['spend'] |
| CTKB |
Cytek Biosciences, Inc. |
36.29 |
1 |
['spend'] |